this page only
Join BIO
|
Member Directory
|
Contact BIO
Home
About BIO
Conferences & Events
Past BIO Events
Industry Calendar
State/Int'l Calendar
Members.BIO.org
BIO News Online
BIO Bulletins
Suggestion Box
Membership Directory
BIO Videos
News & Media
BIO Blogs & Podcasts
National Issues
Health
Food & Agriculture
Industrial & Environmental
• Bioethics
Intellectual Property
Regulatory
Tax & Financial
State & Local Issues
State by State Initiatives
Letters, Testimony & Comments
Speeches & Publications
Industry At-a-Glance
Business & Finance
Monday, October 13, 2008
National Issues
>
Bioethics
>
Backgrounders
>
Human Subjects Protection
Comments on FDA Draft Guidance on Using a Centralized IRB Process
(May 27, 2005)
Protecting Research and Research Participants
Testimony of Charles A. Johnson, MBChB
on behalf of the Biotechnology Industry Organization (BIO) before the Senate Committee on Health, Education, Labor and Pensions
(April 23, 2002)
About advertising opportunities
© 2008 | Biotechnology Industry Organization | 1201 Maryland Ave., SW, Ste. 900 | Washington, D.C. 20024
